| EPB0288 | Influence of the COVID-19 pandemic in the rate of viral suppression of people living with HIV in Mexico under antirretroviral therapy | E-poster | SARS-CoV-2, COVID-19 and HIV |
| LBEPB19 | Factors associated with COVID-19 vaccination uptake amongst PLHIV in southern Nigeria | E-poster | SARS-CoV-2, COVID-19 and HIV |
| TUPEB21 | CMV-Specific IgG changes during severe COVID-19 suggestive of acute reactivation | Poster exhibition | SARS-CoV-2, COVID-19 and HIV |
| EPA0094 | A panel of RBD-specific broadly neutralizing antibodies against SARS-CoV-2 variants | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0095 | Fc-modified HIV-1 broadly neutralizing monoclonal antibody, VRC01LS, shows enhanced biodistribution in human genital and rectal mucosal tissue compared to VRC01 | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0096 | COVID -19 vaccination uptake among adolescents and young people living with HIV in Kenya, 2021-2022 | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0097 | Comparison of immunogenicitiy and neutralizing antibody response of CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) between people living with HIV with CD4 ≤ 200/uL and CD4 >200 cells/uL | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0098 | Heterogeneity in neutralizing antibody responses following COVID-19 vaccination in Japanese people living with HIV | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0099 | No impact of HIV status on COVID-19 vaccine responses in Botswana | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0100 | Serum level of Macrophage migration Inhibitory Factor (MIF) is elevated during acute COVID-19 but not associated with severity, in donors from a biobank from Buenos Aires, Argentina | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |